Author Interviews, Cancer Research, Chemotherapy, JAMA / 25.08.2016
Capecitabine Cancer Treatment Can Result in Loss of Fingerprints
MedicalResearch.com Interview with:
Leni van Doorn, MSc
Department of Medical Oncology
Erasmus MC Cancer Institute
Rotterdam, the Netherlands
MedicalResearch.com: What is the background for this study?
Response: The common cancer treatment capecitabine, a regular treatment for patients mostly diagnosed with breast-, colon- or gastic cancer, induces hand foot syndrome (HFS). HFS is a cutaneous condition that may lead to red palms and blisters in approximately 50% to 60% of the patients and is believed to result in the loss of fingerprints. This fingerprint loss has been described sporadically in the literature.
The main aim of our prospective study was to have a closer look of the association between hand foot syndrome and the loss of fingerprints.
(more…)